Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 4534350, 15 pages
https://doi.org/10.1155/2017/4534350
Research Article

Antimicrobial Activities and Time-Kill Kinetics of Extracts of Selected Ghanaian Mushrooms

Microbiology Section, Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Correspondence should be addressed to Christian Agyare; moc.oohay@eraygasirhc

Received 21 July 2017; Accepted 28 September 2017; Published 29 October 2017

Academic Editor: Letizia Angiolella

Copyright © 2017 Theresa Appiah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Yamac and F. Bilgili, “Antimicrobial activities of fruit bodies and/or mycelial cultures of some mushroom isolates,” Pharmaceutical Biology, vol. 44, no. 8, pp. 660–667, 2006. View at Google Scholar
  2. World Health Organization WHO, Antimicrobial Resistance Secretariat, World Health Organization, Geneva, Switzerland, 2017, http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/.
  3. A. S. Fauci, N. A. Touchette, and G. K. Folkers, “Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases,” Emerging Infectious Diseases, vol. 11, no. 4, pp. 519–525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Livermore, “The need for new antibiotics,” Clinical Microbiology and Infection, Supplement, vol. 10, no. 4, pp. 1–9, 2004. View at Google Scholar · View at Scopus
  5. World Health Organization (WHO), “Human and economic burden. In working to overcome the global impact of neglected tropical diseases,” First WHO Report on Neglected Tropical Diseases, WHO, Geneva, Switzerland, 2017, Doc. WHO/HTM/NTD/2010.1,13-9. View at Google Scholar
  6. R. E. W. Hancock, “Mechanisms of action of newer antibiotics for Gram-positive pathogens,” The Lancet Infectious Diseases, vol. 5, no. 4, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Shahghasi, G. H. Shahidi, M. H. Fooladi, and M. J. Mahdavi, “Broadspectrim, a novel antibacterial from Streptomyces sp,” Biotechnology, vol. 3, no. 2, pp. 26–130, 2004. View at Google Scholar
  8. B. T. Gulgun, “Disruption of Bacterial cell-to-cell communication (Quorum Sensing): a promising novel way to combat bacteria-mediated diseases,” Journal of Marmara University Institute of Health Sciences, vol. 3, no. 3, pp. 159–163, 2013. View at Google Scholar
  9. J. R. Zgoda and J. R. Porter, “A convenient microdilution method for screening natural products against bacteria and fungi,” Pharmaceutical Biology, vol. 39, no. 3, pp. 221–225, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Alves, J. Sallé, S. Chaudy, S. Dupas, and G. Manière, “High-NaCl perception in Drosophila melanogaster,” The Journal of Neuroscience, vol. 34, no. 33, pp. 10884–10891, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Barros, B. A. Venturini, P. Baptista, L. M. Estevinho, and I. C. F. R. Ferreira, “Chemical composition and biological properties of Portuguese wild mushrooms: a comprehensive study,” Journal of Agricultural and Food Chemistry, vol. 56, no. 10, pp. 3856–3862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Zang, J. Xiong, W.-Z. Zhai et al., “Fomentarols A-D, sterols from the polypore macrofungus Fomes fomentarius,” Phytochemistry, vol. 92, pp. 137–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. T. F. Liu, X. Lu, H. Tang, M. M. Zhang, P. Wang, P. Sun et al., “3β,5α,6β-Oxygenated sterols from the South China Sea gorgonian Muriceopsis flavida and their tumor cell growth inhibitory activity and apoptosis-inducing function,” Steroids, vol. 78, no. 1, pp. 108–114, 2013. View at Google Scholar
  14. S. Awala and V. Oyetayo, “Molecular identity and antimicrobial profile of Trametes species Collected from the Teaching and Research Farm of the Federal University of Technology, Akure, Nigeria,” Journal of Advances in Medical and Pharmaceutical Sciences, vol. 4, no. 3, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  15. M. J. Alves, I. C. F. R. Ferreira, H. J. C. Froufe, R. M. V. Abreu, A. Martins, and M. Pintado, “Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR analysis and docking studies,” Journal of Applied Microbiology, vol. 115, no. 2, pp. 346–357, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Cilerdzic, M. Stajic, J. Vukojevic, I. Milovanovic, and N. Muzgonja, “Antioxidant and antifungal potential of Pleurotus ostreatus and Agrocybe cylindracea basidiocarps and mycelia,” Current Pharmaceutical Biotechnology, vol. 16, no. 2, pp. 179–186, 2015. View at Publisher · View at Google Scholar
  17. A. M. Younis, F.-S. Wu, and H. H. El Shikh, “Antimicrobial activity of extracts of the oyster culinary medicinal mushroom Pleurotus ostreatus (higher basidiomycetes) and identification of a new antimicrobial compound,” International Journal of Medicinal Mushrooms, vol. 17, no. 6, pp. 579–590, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Roy and P. Prasad, “Therapeutic potential of Pleurotus ostreatus: A review,” Research Journal of Pharmacy and Technology, vol. 6, no. 9, pp. 937–940, 2013. View at Google Scholar · View at Scopus
  19. A. Turkoglu, M. E. Duru, N. Mercan, I. Kivrak, and K. Gezer, “Antioxidant and antimicrobial activities of Laetiporus sulphureus(Bull.) Murrill,” Food Chemistry, vol. 101, no. 1, pp. 267–273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. E. M. Altuner and I. Akata, “Antimicrobial activity of some macrofungi extracts,” Antimicrobial Activity of Some Macrofungi Extracts, vol. 14, no. 1, pp. 45–49, 2010. View at Google Scholar
  21. K. Praveen, K. Y. Usha, M. Naveen, and B. R. Rajasekhar, “Antibacterial Activity of a Mushroom-Stereum ostrea,” Journal of Biology and Agriclture Healthcare, vol. 2, no. 1, pp. 1–5, 2012. View at Google Scholar
  22. M. A. Lara, A. J. Rodríguez-Malaver, O. J. Rojas et al., “Black liquor lignin biodegradation by Trametes elegans,” International Biodeterioration & Biodegradation, vol. 52, no. 3, pp. 167–173, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Aina, O. Olawuyi, G. Mensah-Agyei, A. Laiya, and M. Adeoye-Isijola, “Comparative phytochemical evaluation, antimicrobial and antioxidant properties of methanolic and ethanolic extracts of Daedalea elegans—a Nigerian Mushroom,” Advance Pharmaceutical Journal, vol. 1, no. 2, pp. 38–42, 2016. View at Google Scholar
  24. J. Ga and V. Kaviyarasana, “Antimicrobial and antioxidant properties of Trametes gibbosa (pers) Fr,” Journal of Pharmacy Research, vol. 4, no. 11, article 39, 2011. View at Google Scholar
  25. G. Zengin, A. Karanfil, M. C. Uren et al., “Phenolic content, antioxidant and enzyme inhibitory capacity of two: Trametes species,” RSC Advances, vol. 6, no. 77, pp. 73351–73357, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Tomasi, F. Lohezic-Le Devehat, P. Sauleau, C. Bézivin, and J. Boustie, “Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines,” Die Pharmazie, vol. 59, no. 4, pp. 290–293, 2004. View at Google Scholar · View at Scopus
  27. M. K. Mbayo, E. M. Kalonda, P. T. Tshisand, O. Tatchoua, S. Kamulete, and K. Glauber, “Chemical Screening of some mushrooms of Katanga (DRC) and their biological activities evaluation,” vol. 10, pp. 435–449, 2015.
  28. M. Kabuyi, P. Kapepula, J. Kabengele, B. Moni, G. Makengo, and P. Mungitshi, “Selenium content and antioxidant potential of some edible wild mushrooms from Bandundu Area, DR Congo,” NaturalResources, vol. 8, no. 2, pp. 103–113, 2017. View at Google Scholar
  29. P. M. Kidd, “The use of mushroom glucans and proteoglycans in cancer treatment,” Alternative Medicine Review, vol. 5, no. 1, pp. 4–27, 2000. View at Google Scholar · View at Scopus
  30. A. M. Tripathi and B. N. Tiwary, “Biochemical constituents of a wild strain of Schizophyllum commune isolated from Achanakmar-Amarkantak Biosphere Reserve (ABR), India,” World Journal of Microbiology and Biotechnology, vol. 29, no. 8, pp. 1431–1442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. M. R. Dulay, J. J. A. Vicente, A. G. Dela Cruz et al., “Antioxidant activity and total phenolic content of Volvariella volvacea and Schizophyllum commune mycelia cultured in indigenous liquid media,” Mycosphere, vol. 7, no. 2, pp. 131–138, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. S. P. Wasser, “Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides,” Applied Microbiology and Biotechnology, vol. 60, no. 3, pp. 258–274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Demirhan, O. F. Yesil, A. Yildiz, and K. A. Gul, “A research on antimicrobial activity of some macro fungi species,” Science and Engineering Journal of Firat University, vol. 19, no. 4, pp. 425–433, 2007. View at Google Scholar
  34. S. C. Punitha and M. Rajasekaran, “Free radical scavenging activity of fruiting body extracts of an edible mushroom, Volvariella volvacea (Bull.ex Fr.) Singer: an in vitro,” Journal of Biomedical and Pharmaceutical Sciences, vol. 4, no. 30, pp. 6–11, 2014. View at Google Scholar
  35. K. Acharya, “Leishmanicidal and anti-candidal activity of constituents of Indian edible mushroom Astraeus hygrometricus,” Chemical Biodiversivity, vol. 9, no. 8, pp. 1517–1524, 2012. View at Google Scholar
  36. S. Maiti, S. K. Bhutia, S. K. Mallick, A. Kumar, N. Khadgi, and T. K. Maiti, “Antiproliferative and immunostimulatory protein fraction from edible mushrooms,” Environmental Toxicology and Pharmacology, vol. 26, no. 2, pp. 187–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Wu, H. Wang, and T. B. Ng, “Purification and characterization of a lectin with antiproliferative activity toward cancer cells from the dried fruit bodies of Lactarius flavidulus,” Carbohydrate Research, vol. 346, no. 16, pp. 2576–2581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. V. Jeurink, C. L. Noguera, H. F. J. Savelkoul, and H. J. Wichers, “Immunomodulatory capacity of fungal proteins on the cytokine production of human peripheral blood mononuclear cells,” International Immunopharmacology, vol. 8, no. 8, pp. 1124–1133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. W. A. S. W. Perera, D. T. U. Abeytunga, and R. L. C, “Antimicrobial activities of Volvariella volvacea,” Jounal of Natural Science Found in Sri Lanka, vol. 29, no. 1&2, pp. 61–68, 2001. View at Google Scholar
  40. R. F. da Silva, A. C. D. A. Barros, M. Pletsch, A. C. Cavalcante Malta Argolo, and B. S. de Araujo, “Study on the scavenging and anti-Staphylococcus aureus activities of the extracts, fractions and subfractions of two Volvariella volvacea strains,” World Journal of Microbiology and Biotechnology, vol. 26, no. 10, pp. 1761–1767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Giri, G. Biswas, P. Pradhan, S. C. Mandal, and K. Acharya, “Antimicrobial activities of basidiocarps of wild edible mushrooms of West Bengal, India,” International Journal of PharmTech Research, vol. 4, no. 4, pp. 1554–1560, 2012. View at Google Scholar · View at Scopus
  42. S. M. K. Ayodele and M. E. Idoko, “Antimicrobial activities of four wild edible mushrooms in Nigeria,” Internatinaol Journl of Science and Nature, vol. 2, no. 1, pp. 55–58, 2011. View at Google Scholar
  43. C. K. Kokate, A. P. Purohit, and S. B. Gokhale, Pharmacognosy, Nirali Prakashan, Pune, India, 32nd edition, 2001.
  44. W. C. Evans, Trease and Evans' Pharmacognosy, Elsevier Health Sciences, Amsterdam, Netherlands, 2009.
  45. M. S. Marica, S. B. A. JIvona, and M. Ana, “Optimization of chromatographic conditions in thin layer chromatography of flavonoids and phenolic acids,” Croatica Chemica Acta, vol. 77, no. 1-2, pp. 361–366, 2010. View at Google Scholar
  46. C. Agyare, G. A. Koffuor, V. E. Boamah, F. Adu, K. B. Mensah, and L. Adu-Amoah, “Antimicrobial and anti-inflammatory activities of Pterygota macrocarpa and Cola gigantea (Sterculiaceae),” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 902394, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Cos, A. J. Vlietinck, D. V. Berghe, and L. Maes, “Anti-infective potential of natural products: how to develop a stronger in vitro proof-of-concept,” Journal of Ethnopharmacology, vol. 106, no. 3, pp. 290–302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. B. T. Tsuji, J. C. Yang, A. Forrest, P. A. Kelchlin, and P. F. Smith, “In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 1, pp. 156–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Obodai, J. Cleland-Okine, and K. A. Vowotor, “Comparative study on the growth and yield of Pleurotus ostreatus mushroom on different lignocellulosic by-products,” Journal of Industrial Microbiology and Biotechnology, vol. 30, no. 3, pp. 146–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. J. W. Kimenju, G. O. M. Odero, E. W. Mutitu, P. M. Wachira, R. D. Narla, and W. M. Muiru, “Suitability of locally available substrates for oyster mushroom (Pleurotus ostreatus) cultivation in Kenya,” Asian Journal of Plant Sciences, vol. 8, no. 7, pp. 510–514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Wang, L. Bao, F. Zhao et al., “Isolation, identification, and bioactivity of monoterpenoids and sesquiterpenoids from the mycelia of edible mushroom pleurotus cornucopiae,” Journal of Agricultural and Food Chemistry, vol. 61, no. 21, pp. 5122–5129, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. M. K. Kim, R. K. Math, K. M. Cho et al., “Effect of Pseudomonas sp. P7014 on the growth of edible mushroom Pleurotus eryngii in bottle culture for commercial production,” Bioresource Technology, vol. 99, no. 8, pp. 3306–3308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Prasad and W. E. G. Wesely, “Antibacterial activity of the bio-multidrug (Ganoderma lucidum) on Multidrug resistant Staphylococcus aureus (MRSA),” Journal of Advanced Biotechnology, vol. 10, p. 16, 2008. View at Google Scholar
  54. M. T. G. Silva, S. M. Simas, T. G. Batista, P. Cardarelli, and T. C. B. Tomassini, “Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination,” Memórias do Instituto Oswaldo Cruz, vol. 100, no. 7, pp. 779–782, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. O. Keleş, T. Bakirel, S. Şener, G. Baktir, G. Daǧoǧlu, and O. Özkan, “Pharmacokinetics and tissue levels of tilmicosin in fowls,” Turkish Journal of Veterinary & Animal Sciences, vol. 25, no. 4, pp. 629–634, 2001. View at Google Scholar · View at Scopus
  56. K. Dornberger, W. Ihn, W. Schade, D. Tresselt, A. Zureck, and L. Radics, “Antibiotics from basidiomycetes evidence for the occurrence of the 4-hydroxybenzenediazonium ion in the extracts of agaricus xanthodermus genevier (agaricales),” Tetrahedron Letters, vol. 27, no. 5, pp. 559-560, 1986. View at Publisher · View at Google Scholar · View at Scopus
  57. V. E. C. Ooi and F. A. Liu, “A review of pharmacological activities of mushroom polysaccharides,” International Journal of Medicinal Mushrooms, vol. 1, no. 3, pp. 195–206, 1991. View at Google Scholar
  58. H. Matsuyama, R. E. P. Mangindaan, and T. Yano, “Protective effect of schizophyllan and scleroglucan against Streptococcus sp. infection in yellowtail (Seriola quinqueradiata),” Aquaculture, vol. 102, no. 3-4, pp. 197–203, 1992. View at Publisher · View at Google Scholar · View at Scopus
  59. I. Suay, F. Arenal, F. J. Asensio, A. Basilio, M. A. Cabello, and M. T. Diez, “Screening of Basidiomycetes for antimicrobial activities,” Anton Van Leeuwen, vol. 78, no. 3, pp. 3–8, 2000. View at Google Scholar
  60. C. Papadopoulou, K. Soulti, and I. G. Roussis, “Potential antimicrobial activity of red and white wine phenolic extracts against strains of staphylococcus aureus, escherichia coli and Candida albicans,” ood Technology and Biotechnology, vol. 43, no. 1, pp. 41–46, 2005. View at Google Scholar · View at Scopus
  61. G. Nagaraj, M. V. Uma, M. S. Shivayogi, and H. Balaram, “Antimalarial activities of peptide antibiotics isolated from fungi,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 1, pp. 145–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Kalyoncu, M. Oskay, H. Sağlam, T. F. Erdoğan, and A. U. Tamer, “Antimicrobial and antioxidant activities of mycelia of 10 wild mushroom species,” Journal of Medicinal Food, vol. 13, no. 2, pp. 415–419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. T. R. Keepers, M. Gomez, C. Celeri, W. W. Nichols, and K. M. Krause, “Bactericidal activity, absence of serum effect, and time-kill kinetics of ceftazidime-avibactam against β-lactamase-producing enterobacteriaceae and Pseudomonas aeruginosa,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 9, pp. 5297–5305, 2014. View at Publisher · View at Google Scholar
  64. G. A. Pankey and L. D. Sabath, “Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections,” Clinical Infectious Diseases, vol. 38, no. 6, pp. 864–870, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. Z. Aumeeruddy-Elalfi, A. Gurib-Fakim, and M. F. Mahomoodally, “Chemical composition, antimicrobial and antibiotic potentiating activity of essential oils from 10 tropical medicinal plants from Mauritius,” Journal of Herbal Medicine, vol. 6, no. 2, pp. 88–95, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. D. Boakye, C. Agyare, and H. Andreas, “Anti-infective properties and time-kill kinetics of Phyllanthus muellerianus and its major constituent, geraniin,” Medicinal Chemistry, vol. 6, no. 2, pp. 95–104, 2016. View at Google Scholar
  67. S. Tinrat, “Antimicrobial activities and synergistic effects of the combination of some edible mushroom extracts with antibiotics against pathogenic strains,” International Journal of Pharmaceutical Sciences Review and Research, vol. 35, no. 2, pp. 253–262, 2015. View at Google Scholar · View at Scopus